Tectonic Therapeutic, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2017 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Tectonic Therapeutic, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2017 to Q3 2024.
Tectonic Therapeutic, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.65M, a 500% increase year-over-year.
Tectonic Therapeutic, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.74M, a 26.3% increase year-over-year.
Tectonic Therapeutic, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.89M, a 40.2% decline from 2022.
Tectonic Therapeutic, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.5M, a 38% decline from 2021.
Tectonic Therapeutic, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $18.6M, a 18.9% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$6.74M	$1.65M	+$1.38M	+500%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$5.37M	$403K	+$126K	+45.5%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$5.24M	$878K	-$1.65M	-65.3%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$6.89M	$3.81M	+$1.56M	+69%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-14
Q3 2023	$5.34M	$275K	-$2.38M	-89.6%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-12
Q2 2023	$7.72M	$277K	-$2.96M	-91.4%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-14
Q1 2023	$10.7M	$2.53M	-$848K	-25.1%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$11.5M	$2.25M	-$1.83M	-44.8%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-14
Q3 2022	$13.4M	$2.66M	-$2.51M	-48.6%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	$15.9M	$3.23M	-$1.46M	-31.1%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	$17.3M	$3.38M	-$1.26M	-27.1%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$18.6M	$4.08M	-$18K	-0.44%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-23
Q3 2021	$18.6M	$5.17M	+$364K	+7.58%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	$18.2M	$4.69M	+$792K	+20.3%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	$17.4M	$4.64M	+$1.81M	+64.2%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	$15.6M	$4.1M	+$2.22M	+118%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-17
Q3 2020	$13.4M	$4.81M	+$3.01M	+167%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$10.4M	$3.9M	+$2.24M	+134%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$8.17M	$2.82M	+$1.37M	+94%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q4 2019	$6.8M	$1.89M	+$805K	+74.5%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-18
Q3 2019	$6M	$1.8M	+$1.25M	+227%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$4.75M	$1.66M	+$1.21M	+264%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	$3.54M	$1.46M	+$1.35M	+1235%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$2.2M	$1.08M			Oct 1, 2018	Dec 31, 2018	10-K	2020-03-16
Q3 2018		$550K	+$504K	+1096%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018		$457K			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018		$109K			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-13
Q3 2017		$46K			Jun 24, 2017	Sep 30, 2017	10-Q	2018-11-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.